Drugs in the Pipeline Denosumab Biosimilar for Osteoporosis, Other Conditions Under FDA Review By Diana Ernst, RPh Publish Date February 6, 2023
News Adjuvant Therapy Recommendations for Breast Cancer Drop Between Ages 69 and 70 Publish Date February 6, 2023
News NSCLC Survival Improved With FDG PET/CT Imaging Before Radiation Therapy Publish Date February 6, 2023
News Trodelvy Approved for Pretreated HR+/HER2- Metastatic Breast Cancer By Brian Park, PharmD Publish Date February 3, 2023
News Turalio Dosing Regimen Updated for Tenosynovial Giant Cell Tumor By Brian Park, PharmD Publish Date February 1, 2023
News Orserdu Approved for ER+, HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer By Brian Park, PharmD Publish Date January 30, 2023
News Jaypirca Approved for Relapsed/Refractory Mantle Cell Lymphoma By Diana Ernst, RPh Publish Date January 27, 2023
News Keytruda Approved as Adjuvant Treatment for Stage IB, II, or IIIA NSCLC By Diana Ernst, RPh Publish Date January 27, 2023
Drugs in the Pipeline Trial Evaluating Lisocabtagene Maraleucel for Relapsed/Refractory CLL Meets Endpoint By Diana Ernst, RPh Publish Date January 26, 2023
Drugs in the Pipeline Trial Investigating Pembrolizumab for Hormone-Sensitive Prostate Cancer Discontinued By Diana Ernst, RPh Publish Date January 25, 2023
Drugs in the Pipeline Avapritinib Gets Priority Review for Indolent Systemic Mastocytosis By Brian Park, PharmD Publish Date January 23, 2023
News Effectiveness of Corticosteroids in Treating Chemotherapy-Induced Thrombocytopenia By Lauren Dembeck, PhD Publish Date January 23, 2023
News Brukinsa Gains Approval for Chronic Lymphocytic Leukemia By Brian Park, PharmD Publish Date January 20, 2023
News Risk for Advanced Neoplasm Low 10+ Years After Negative Colonoscopy Publish Date January 20, 2023
News Tukysa Combo Approved for RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer By Brian Park, PharmD Publish Date January 19, 2023
Drugs in the Pipeline Immunotherapy Combo Reduces Risk of Cancer Recurrence in Early-Stage Liver Cancer By Brian Park, PharmD Publish Date January 19, 2023
News Prostate Cancer ADT Increases Bone Fracture Risk By Jody A. Charnow Publish Date January 17, 2023
News PD-1 Inhibitor Treatment Effective for Localized Mismatch Repair-Deficient CRC Publish Date January 17, 2023